Published in Clin Infect Dis on January 15, 2009
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 11.12
Clinical management of Staphylococcus aureus bacteremia: a review. JAMA (2014) 3.29
Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev (2012) 2.18
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol (2012) 1.49
Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med (2010) 1.43
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc (2011) 1.33
Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med (2011) 1.32
Catheter-related bloodstream infections. Int J Crit Illn Inj Sci (2014) 1.08
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model. Antimicrob Agents Chemother (2009) 0.96
Clinical update on linezolid in the treatment of Gram-positive bacterial infections. Infect Drug Resist (2012) 0.95
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol (2011) 0.92
Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit. Crit Care (2009) 0.87
Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia. Antimicrob Agents Chemother (2012) 0.84
The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections. PLoS One (2013) 0.83
Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol (2016) 0.83
Prevention of vancomycin induced nephrotoxicity: a review of preclinical data. Eur J Clin Pharmacol (2012) 0.81
Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Pharmacol Toxicol (2013) 0.81
Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study. Clinicoecon Outcomes Res (2014) 0.81
Current strategies for the prevention and management of central line-associated bloodstream infections. Infect Drug Resist (2010) 0.80
Acquisition of resistant microorganisms and infections in HIV-infected patients admitted to the ICU. Eur J Clin Microbiol Infect Dis (2013) 0.79
Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study". Clin Infect Dis (2009) 0.79
An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy. Core Evid (2012) 0.79
Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design. Mayo Clin Proc (2012) 0.79
Noninferiority of linezolid for skin and bloodstream infections. Clin Infect Dis (2009) 0.77
New developments in the management of severe skin and deep skin structure infections - focus on tedizolid. Ther Clin Risk Manag (2015) 0.77
Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis. J Antibiot (Tokyo) (2015) 0.77
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Infect Chemother (2016) 0.75
Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection. Antimicrob Agents Chemother (2016) 0.75
Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study. Eur J Clin Microbiol Infect Dis (2016) 0.75
A propensity score analysis shows that empirical treatment with linezolid does not increase the thirty-day mortality rate in patients with Gram-negative bacteremia. Antimicrob Agents Chemother (2014) 0.75
Efficacy and safety of linezolid for the treatment of infections in children: a meta-analysis. Eur J Pediatr (2014) 0.75
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med (2013) 11.44
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 11.12
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest (2003) 5.64
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis (2007) 5.15
Azithromycin for the secondary prevention of coronary events. N Engl J Med (2005) 3.42
Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis (2004) 3.35
Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis (2005) 3.14
A comprehensive regulatory framework to address the unmet need for new antibacterial treatments. Lancet Infect Dis (2013) 2.91
Pay for performance in critical care: an executive summary of the position paper by the Society of Critical Care Medicine. Crit Care Med (2009) 2.78
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother (2005) 2.66
Nocardiosis at the turn of the century. Medicine (Baltimore) (2009) 2.55
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med (2004) 2.30
Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis (2005) 2.27
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species. Antimicrob Agents Chemother (2008) 2.11
Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care (2010) 1.97
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother (2003) 1.85
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis (2006) 1.67
Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis (2005) 1.66
Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. J Infect Dis (2013) 1.61
Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med (2007) 1.56
Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement. J Infect Dis (2003) 1.54
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med (2015) 1.54
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (2002) 1.53
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.50
Factors influencing hospital length of stay after robotic totally endoscopic coronary artery bypass grafting. Ann Thorac Surg (2013) 1.49
Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Clin Infect Dis (2008) 1.48
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother (2006) 1.46
Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. J Clin Microbiol (2005) 1.45
Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? Intensive Care Med (2009) 1.44
[Severe acute respiratory syndrome (SARS)]. Med Klin (Munich) (2003) 1.42
Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) (2007) 1.41
Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore) (2010) 1.39
Bias associated with mining electronic health records. J Biomed Discov Collab (2011) 1.36
Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob Agents Chemother (2004) 1.34
Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am J Trop Med Hyg (2006) 1.29
Analysis of changes in recent tuberculosis transmission patterns after a sharp increase in immigration. J Clin Microbiol (2006) 1.29
Isolation of Mycobacterium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category. J Clin Microbiol (2011) 1.28
Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) (2008) 1.27
Using discordance to improve classification in narrative clinical databases: an application to community-acquired pneumonia. Comput Biol Med (2006) 1.27
Advanced survey of tuberculosis transmission in a complex socioepidemiologic scenario with a high proportion of cases in immigrants. Clin Infect Dis (2008) 1.26
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. J Antimicrob Chemother (2005) 1.26
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J (2007) 1.26
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg (2010) 1.22
Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis (2004) 1.19
Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med (2009) 1.19
Evaluation of the new advanced 15-loci MIRU-VNTR genotyping tool in Mycobacterium tuberculosis molecular epidemiology studies. BMC Microbiol (2008) 1.19
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis (2006) 1.17
Analysis of clonal composition of Mycobacterium tuberculosis isolates in primary infections in children. J Clin Microbiol (2004) 1.16
Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods. J Clin Microbiol (2009) 1.16
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med (2008) 1.16
Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care (2009) 1.16
Analysis of Mycobacterium tuberculosis genotypes in Madrid and identification of two new families specific to Spain-related settings. J Clin Microbiol (2005) 1.16
Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (2003) 1.16
Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season? Crit Care (2012) 1.14
HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One (2013) 1.13
The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture. Tuberculosis (Edinb) (2010) 1.13
Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch Intern Med (2002) 1.12
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother (2006) 1.12
Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. Antimicrob Agents Chemother (2004) 1.11
Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J Antimicrob Chemother (2005) 1.10
Extra-abdominal infections due to Gemella species. Int J Infect Dis (2002) 1.09
PCR for detection of herpes simplex virus in cerebrospinal fluid: alternative acceptance criteria for diagnostic workup. J Clin Microbiol (2013) 1.08
Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob Agents Chemother (2013) 1.08
Rapid clonal analysis of recurrent tuberculosis by direct MIRU-VNTR typing on stored isolates. BMC Microbiol (2007) 1.07
Association between the infectivity of Mycobacterium tuberculosis strains and their efficiency for extrarespiratory infection. J Infect Dis (2005) 1.06
Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother (2002) 1.06
Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets. Vet Microbiol (2009) 1.05
Prospective universal application of mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping to characterize Mycobacterium tuberculosis isolates for fast identification of clustered and orphan cases. J Clin Microbiol (2009) 1.05
BK virus in heart transplant recipients: a prospective study. J Heart Lung Transplant (2010) 1.05
Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections. Future Microbiol (2008) 1.03
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era. Antimicrob Agents Chemother (2008) 1.03
Systematic survey of clonal complexity in tuberculosis at a populational level and detailed characterization of the isolates involved. J Clin Microbiol (2011) 1.02
Complex clonal features in an mycobacterium tuberculosis infection in a two-year-old child. Pediatr Infect Dis J (2006) 1.01
Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis. J Clin Microbiol (2011) 0.99
Bacteremia due to Roseomonas spp. Clin Microbiol Infect (1998) 0.99
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes. Antimicrob Agents Chemother (2007) 0.98
Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients. Diagn Microbiol Infect Dis (2011) 0.98
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob Agents Chemother (2006) 0.98
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary. Am J Health Syst Pharm (2013) 0.98
Relation of antibiotic use to risk of myocardial infarction in the general population. Am J Cardiol (2002) 0.98
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis (2006) 0.97
Impact of laboratory cross-contamination on molecular epidemiology studies of tuberculosis. J Clin Microbiol (2006) 0.97
Rapid detection of Staphylococcus aureus in lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay. J Clin Microbiol (2012) 0.96
Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity. Antimicrob Agents Chemother (2005) 0.96
Characterization of multiple isolates of Aspergillus fumigatus from patients: genotype, mating type and invasiveness. Med Mycol (2009) 0.96
Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol (2007) 0.96
Chlamydophila pneumoniae. Infect Dis Clin North Am (2010) 0.95
Is vasoplegic syndrome more prevalent with open-heart procedures compared with isolated on-pump CABG surgery? Cardiovasc Revasc Med (2011) 0.95
Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis (2003) 0.94
Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole. Diagn Microbiol Infect Dis (2002) 0.94
Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07. Med Klin (Munich) (2009) 0.94
Characterization of microevolution events in Mycobacterium tuberculosis strains involved in recent transmission clusters. J Clin Microbiol (2011) 0.94
Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol (2008) 0.93
Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol (2008) 0.93
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations. Antimicrob Agents Chemother (2011) 0.93
Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain. Med Mycol (2010) 0.92
Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? J Heart Lung Transplant (2007) 0.92
Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine (Baltimore) (2015) 0.91